Gerald B. Appel

2.1k total citations
19 papers, 1.4k citations indexed

About

Gerald B. Appel is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Gerald B. Appel has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 10 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Gerald B. Appel's work include Renal Diseases and Glomerulopathies (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Gerald B. Appel is often cited by papers focused on Renal Diseases and Glomerulopathies (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Gerald B. Appel collaborates with scholars based in United States and Italy. Gerald B. Appel's co-authors include Anthony M. Valeri, Vivette D. D’Agati, Glen S. Markowitz, Michael B. Stokes, Robert L. Seigle, Laura Barisoni, Samih H. Nasr, Neeraja Kambham, Julie Lin and William H. Sherman and has published in prestigious journals such as New England Journal of Medicine, Kidney International and The American Journal of Medicine.

In The Last Decade

Gerald B. Appel

19 papers receiving 1.4k citations

Peers

Gerald B. Appel
R Habib France
Beatrijs Oortwijn Netherlands
A Rifai United States
N. Gunnar Westberg United States
A Darnell Spain
R Habib France
Gerald B. Appel
Citations per year, relative to Gerald B. Appel Gerald B. Appel (= 1×) peers R Habib

Countries citing papers authored by Gerald B. Appel

Since Specialization
Citations

This map shows the geographic impact of Gerald B. Appel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald B. Appel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald B. Appel more than expected).

Fields of papers citing papers by Gerald B. Appel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald B. Appel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald B. Appel. The network helps show where Gerald B. Appel may publish in the future.

Co-authorship network of co-authors of Gerald B. Appel

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald B. Appel. A scholar is included among the top collaborators of Gerald B. Appel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald B. Appel. Gerald B. Appel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Batal, Ibrahim, Samih H. Nasr, Surendra Dasari, et al.. (2023). Pathologic-genomic correlation identified a novel variant in FN1 and established the diagnosis of recurrent fibronectin glomerulopathy in the kidney allograft. American Journal of Transplantation. 24(3). 498–502. 3 indexed citations
2.
Santoriello, Dominick, Andrew S. Bomback, Satoru Kudose, et al.. (2021). Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine. Kidney International. 100(2). 440–446. 23 indexed citations
3.
Jeyabalan, Anushya, Ibrahim Batal, Doloretta Piras, Heather Morris, & Gerald B. Appel. (2020). Familial Fibrillary Glomerulonephritis in Living Related Kidney Transplantation. Kidney International Reports. 6(1). 239–242. 4 indexed citations
4.
Khairallah, Pascale, Russell J. Crew, Xiaoyi Ye, et al.. (2019). Clinicopathologic Assessment of Monoclonal Immunoglobulin-associated Renal Disease in the Kidney Allograft: A Retrospective Study and Review of the Literature. Transplantation. 104(7). 1341–1349. 6 indexed citations
5.
Hogan, John, Pietro A. Canetta, Leal Herlitz, et al.. (2014). Rituximab treatment for fibrillary glomerulonephritis. Nephrology Dialysis Transplantation. 29(10). 1925–1931. 36 indexed citations
6.
Herlitz, Leal, Andrew S. Bomback, Glen S. Markowitz, et al.. (2012). Pathology after Eculizumab in Dense Deposit Disease and C3 GN. Journal of the American Society of Nephrology. 23(7). 1229–1237. 119 indexed citations
7.
Nasr, Samih H., Anjali A. Satoskar, Glen S. Markowitz, et al.. (2009). Proliferative Glomerulonephritis with Monoclonal IgG Deposits. Journal of the American Society of Nephrology. 20(9). 2055–2064. 275 indexed citations
8.
Nasr, Samih H., Dean C. Preddie, Glen S. Markowitz, Gerald B. Appel, & Vivette D. D’Agati. (2006). Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes. Kidney International. 69(3). 616–620. 32 indexed citations
9.
Appel, Gerald B.. (2006). Improved outcomes in nephrotic syndrome.. Cleveland Clinic Journal of Medicine. 73(2). 161–167. 4 indexed citations
10.
Rosenstock, Jordan L., Glen S. Markowitz, Anthony M. Valeri, et al.. (2003). Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features. Kidney International. 63(4). 1450–1461. 218 indexed citations
11.
Lin, Julie, Glen S. Markowitz, Anthony M. Valeri, et al.. (2001). Renal Monoclonal Immunoglobulin Deposition Disease. Journal of the American Society of Nephrology. 12(7). 1482–1492. 265 indexed citations
12.
Appel, Gerald B.. (1997). Cyclophosphamide therapy of severe lupus nephritis. American Journal of Kidney Diseases. 30(6). 872–876. 5 indexed citations
13.
Valeri, Anthony M., et al.. (1996). Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney International. 50(5). 1734–1746. 215 indexed citations
14.
Sehgal, Vinita, Jai Radhakrishnan, Gerald B. Appel, Anthony M. Valeri, & David J. Cohen. (1995). Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension. American Journal of Kidney Diseases. 26(1). 193–201. 46 indexed citations
15.
Carbone, Laura, Vivette D. D’Agati, Jen-Tse Cheng, & Gerald B. Appel. (1989). Course and prognosis of human immunodeficiency virus-associated nephropathy☆. The American Journal of Medicine. 87. 389–395. 8 indexed citations
16.
D’Agati, Vivette D., Neil D. Theise, Conrad L. Pirani, Dan Knowles, & Gerald B. Appel. (1989). Interstitial nephritis related to nonsteroidal anti-inflammatory agents and beta-lactam antibiotics: a comparative study of the interstitial infiltrates using monoclonal antibodies.. PubMed. 2(4). 390–6. 24 indexed citations
17.
D’Agati, Vivette D., et al.. (1986). Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. Kidney International. 30(4). 573–581. 75 indexed citations
18.
Truong, Luan D., et al.. (1985). Thrombotic Thrombocytopenic Purpura Syndrome in Systemic Lupus Erythematosus: Treatment With Plasma Infusion. American Journal of Kidney Diseases. 6(3). 154–160. 37 indexed citations
19.
Appel, Gerald B. & Harold C. Neu. (1977). The nephrotoxicity of antimicrobial agents Pt 3.. New England Journal of Medicine. 296(14). 784–787. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026